Frontiers in Immunology (Dec 2021)

Dual UMIs and Dual Barcodes With Minimal PCR Amplification Removes Artifacts and Acquires Accurate Antibody Repertoire

  • Qilong Wang,
  • Qilong Wang,
  • Huikun Zeng,
  • Huikun Zeng,
  • Yan Zhu,
  • Yan Zhu,
  • Minhui Wang,
  • Yanfang Zhang,
  • Yanfang Zhang,
  • Xiujia Yang,
  • Xiujia Yang,
  • Haipei Tang,
  • Haipei Tang,
  • Hongliang Li,
  • Yuan Chen,
  • Yuan Chen,
  • Cuiyu Ma,
  • Chunhong Lan,
  • Chunhong Lan,
  • Chunhong Lan,
  • Chunhong Lan,
  • Bin Liu,
  • Wei Yang,
  • Xueqing Yu,
  • Xueqing Yu,
  • Zhenhai Zhang,
  • Zhenhai Zhang,
  • Zhenhai Zhang,
  • Zhenhai Zhang,
  • Zhenhai Zhang

DOI
https://doi.org/10.3389/fimmu.2021.778298
Journal volume & issue
Vol. 12

Abstract

Read online

Antibody repertoire sequencing (Rep-seq) has been widely used to reveal repertoire dynamics and to interrogate antibodies of interest at single nucleotide-level resolution. However, polymerase chain reaction (PCR) amplification introduces extensive artifacts including chimeras and nucleotide errors, leading to false discovery of antibodies and incorrect assessment of somatic hypermutations (SHMs) which subsequently mislead downstream investigations. Here, a novel approach named DUMPArts, which improves the accuracy of antibody repertoires by labeling each sample with dual barcodes and each molecule with dual unique molecular identifiers (UMIs) via minimal PCR amplification to remove artifacts, is developed. Tested by ultra-deep Rep-seq data, DUMPArts removed inter-sample chimeras, which cause artifactual shared clones and constitute approximately 15% of reads in the library, as well as intra-sample chimeras with erroneous SHMs and constituting approximately 20% of the reads, and corrected base errors and amplification biases by consensus building. The removal of these artifacts will provide an accurate assessment of antibody repertoires and benefit related studies, especially mAb discovery and antibody-guided vaccine design.

Keywords